IP Library › Assignment 063810/0171
Patent Assignment
Reel/Frame 063810/0171

Merger

Recorded: 2023-05-31 Pages: 4
Assignor
CONCERT PHARMACEUTICALS, INC.
Executed: 2023-03-28
Assignee
SUN PHARMACEUTICALS INDUSTRIES, INC.
2 INDEPENDENCE WAY, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Deuterated Derivatives of Ruxolitinib
Patent: 9,249,149 →
Application: 14/707,912 →
Publication: US 2015/0239896
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 14, 2015
From: SILVERMAN, I. ROBERT; LIU, JULIE F.; MORGAN, ADAM J.; PANDYA, BHAUMIK
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 035947/0680 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 063810 Frame: 0171. Assignor(S) Hereby Confirms the Merger. Jul 20, 2023
From: CONCERT PHARMACEUTICALS, INC.
To: SUN PHARMACEUTICAL INDUSTRIES, INC.
Reel/Frame 064351/0516 →